SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-20-199664
Filing Date
2020-07-27
Accepted
2020-07-27 16:06:00
Documents
2
Period of Report
2020-07-27

Document Format Files

Seq Description Document Type Size
1 6-K d78408d6k.htm 6-K 11806
2 EX-99.1 d78408dex991.htm EX-99.1 504272
  Complete submission text file 0001193125-20-199664.txt   517200
Mailing Address 136A EASTERN AVENUE MILTON PARK ABINGDON X0 OX14 4SB
Business Address 136A EASTERN AVENUE MILTON PARK ABINGDON X0 OX14 4SB 44-123-544-3939
Summit Therapeutics plc (Filer) CIK: 0001599298 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 0131
Type: 6-K | Act: 34 | File No.: 001-36866 | Film No.: 201050500
SIC: 2834 Pharmaceutical Preparations